Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

UBS raises Nasdaq OMX shares target citing potential organic solutions growth

EditorEmilio Ghigini
Published 04/29/2024, 06:46 AM
NDAQ
-

On Monday, UBS updated its outlook on Nasdaq OMX Group Inc. (NASDAQ: NDAQ) shares, increasing the firm's price target from $60.00 to $68.00, while maintaining a Neutral rating. The adjustment follows the first quarter results of 2024, which prompted a review of the company's medium-term growth potential.

According to UBS, Nasdaq's accelerating growth in organic solutions is expected to bring its valuation more in line with its information services peers. However, the firm also noted a reduction in earnings per share (EPS) estimates by 2-3%, which remains significantly lower than the consensus on the Street. This tempered view reflects several factors impacting Nasdaq's business trajectory.

The firm anticipates a near-term slowdown in organic growth due to tougher comparisons in the index segment and continued subdued performance in several of Nasdaq's legacy solutions businesses. Furthermore, UBS expects the high-margin trading businesses to experience a downturn over the year.

Despite the positive performance of Adenza, Nasdaq's financial software and risk management company, concerns remain. UBS highlighted that with leverage still above 4% and private equity lock-ups expiring in June, the contribution from Adenza may not be sufficient to counterbalance other headwinds. Additionally, the recent decline in peer group multiples poses challenges to Nasdaq's valuation case.

In summary, while UBS acknowledges the potential for Nasdaq's organic solutions growth to enhance its relative valuation, the firm remains cautious due to lower EPS estimates, anticipated growth deceleration, and broader market conditions affecting trading businesses and valuation multiples.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.